Holy Grail Company, a Hemp and CBD Company, (OTC Symbol:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
56
Holy Grail Company, a Hemp and CBD Company, (OTC Symbol: HGRL) is Proud to Announce the Recent Success of Their Hemp Water, Holy Water

TEMECULA, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Holy Grail Company (OTC:HGRL) is excited to see its expansion with three new distribution partners in the month of April. These new distributors are enthusiastic about the promotion of Holy Water as their flagship product offering, with the expectation of expansion into the full line in the future.

Holy Water is available in 16.9 oz and 1 liter sizes. Each 16.9 oz offers 1 serving of Holy Grail hemp. The water goes through a seven-step purification process, as well as a mineral and hemp/CBD infusion creating a perfectly balanced 9+pH water with a sensational taste. Look for it in stores near you. 

“The company is driven by its support of strong distribution channels in various vertical markets including C-Stores, Gas Stations, and Vape and Smoke Shops. These distribution partners allow us a larger reach and local support to retailers. We highly value current and future partnerships that will drive branding, and positive revenue for the company.” -Jason Golec, Co-CEO, Holy Grail Company.

“In April we were able to expand distribution with what we believe to be three key distribution companies found in Arizona, Missouri, and South Carolina. The company feels that this will allow for a larger market share not only in these states, but neighboring areas as well.” -Eddie Quiroz, Co-CEO Holy Grail Company.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Holy Grail Company/ Haenep’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. Holy Grail Company/ Haenep disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact Holy Grail Company/ Haenep’s forward-looking statements, please see Holy Grails/ Haenep’s filings on OTC Markets (OTC:HGRL).

For more information please visit us at: www.HolyGrailCompany.com Phone: 866-699-5396

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Isopropanol Market Expected to Reach US$ 6.95 Billion

Updated Category News Views 107

Overview of the Global Isopropanol Market A recent report indicates that the global isopropanol market is set to grow from USD 3.43 billion to USD 6.95 billion, achieving a compound annual growth rate (CAGR) of 7.3% during the forecast period. The Asia Pacific region is expected to dominate the market, capturing a significant share of the revenue. This growth is largely...

Continue Reading
Dynatrace Launches Innovative Observability Solutions for Devs

Updated Category News Views 517

Observability Solutions Tailored for Developers LAS VEGAS-- Dynatrace (NYSE: DT), a leader in AI-powered observability, recently announced the launch of Observability for Developers. This comprehensive suite of solutions aims to equip the developer community with essential runtime insights and troubleshooting capabilities, accelerating the much-needed 'shift-left'...

Continue Reading
Man Group PLC Shares and Position Disclosure Insights

Updated Category News Views 111

Understanding Man Group PLC's Position Disclosure Man Group PLC, a prominent global investment management firm, recently shared a crucial disclosure regarding its interests in securities related to Tritax Big Box REIT plc. This disclosure, in alignment with the UK Takeover Code, is pivotal for transparency and investor awareness. Notably, the firm has reported holding...

Continue Reading
Blackbaud Finalizes Sale of EVERFI to Private Investment Firm

Updated Category News Views 863

Blackbaud Completes Sale of EVERFI Blackbaud, Inc. (NASDAQ: BLKB), a leading software company that prioritizes social impact, has finalized the sale of its EVERFI business. This decision aligns with Blackbaud's ongoing focus on its core services and strategic objectives. Financial Overview and Strategic Review The sale, which was made to a private investment firm, is set...

Continue Reading
Apple's Strategic Move into AI-Enabled Smartphones Revealed

Updated Category News Views 175

Apple's Market Position and Recent Developments Apple (NASDAQ: AAPL) continues to hold its title as the world’s most valuable company, with an impressive market capitalization of about $3.3 trillion. The surge in demand for Apple's flagship device, the iPhone, plays a crucial role in reaching this valuation. However, recent reports indicate a dip in stock prices...

Continue Reading